• OPEN AN ACCOUNT
Indian Indices
Nifty
24,750.70 -82.90
(-0.33%)
Sensex
81,451.01 -182.01
( -0.22%)
Bank Nifty
55,749.70 203.65
( 0.37%)
Nifty IT
37,321.75 -432.40
( -1.15%)
Global Indices
Nasdaq
42,280.67 43.94
(0.10%)
Dow Jones
5,931.28 -1.89
(-0.03%)
Hang Seng
38,097.61 -335.37
(-0.87%)
Nikkei 225
8,772.38 55.93
(0.64%)
Forex
USD-INR
85.50 0.07
(0.09%)
EUR-INR
97.01 0.42
(0.44%)
GBP-INR
115.18 0.03
(0.03%)
JPY-INR
0.59 0.00
(0.53%)

EQUITY - MARKET SCREENER

Marksans Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524404
INE750C01026
30.5295026
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MARKSANS
63.02
11852.5
EPS(TTM)
Face Value()
Div & Yield %
4.15
1
0.31
 

Hemisphere Properties India Ltd - Announcement under Regulation 30 (LODR)-Change in Directorate
Apr 21,2025
Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 Ministry of Housing and Urban Affairs (MoHUA) Government of India vide its Office Order dated 21.04.2025 Shri G R Kanakavidu has been appointed as Independent Director on the Board of HPIL w.e.f. 21.04.2025 for a period of one year from the date of notification of their appointment (i.e. 21.04.2025) or until further orders whichever is earlier. Further it is hereby informed that Shri G R Kanakavidu Independent Director has furnished a declaration that he has not debarred from holding the office of Director pursuant to any SEBI order or order of any other such authority. In this regard brief profile of Shri G R Kanakavidu is enclosed as Annexure-1